Search research articles
Contact Us
Filters
Showing results (171-180 of 432) with videos related to
Page
of 44
Sort By:
Thrombosis Et Diathesis Haemorrhagica
|
December 31, 1974
Fibrinogen Valencia. A new case of congenital dysfibrinogenemia
J Aznar, A Fernandez-Pavón, E Regañón, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1996
Comparative in-vitro activity of sparfloxacin against genital pathogens
E J Perea, J Aznar, M C Garcia-Iglesias, et al.
Thrombosis and Haemostasis
|
August 24, 1999
Intraindividual variability in plasma viscosity in relation to their utility as a cardiovascular risk factor
A Vayá, M Martínez, C Ortuño, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
May 1, 1981
Clinical experience with cefotaxime (HR-756) in surgical patients
J Aznar, E Muñoz, M C García-Iglesias, et al.
Sangre
|
January 1, 1975
[Fibrinolytic activity of human endometrium saline extract (author's transl)]
J J Parrilla, J Aznar, A Estelles, et al.
Thrombosis Research
|
December 15, 1989
Aprotinin (trasylol) is a competitive inhibitor of activated protein C
F España, A Estelles, J H Griffin, et al.
Thrombosis Research
|
November 15, 1989
Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism
M D Tabernero, A Estellés, V Vicente, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 1, 1989
[In situ hybridization with DNA probe for the diagnosis of Neisseria gonorrhoeae infections]
J C Palomares, M C Lozano, J Aznar, et al.
Thrombosis and Haemostasis
|
April 30, 1976
Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancy
J Aznar, A Hernandez, J J Parrilla, et al.
Atherosclerosis
|
January 1, 1984
Effect of smoking on plasma and platelet fatty acid composition in middle-aged men
M T Santos, J Valles, J Aznar, et al.
Page
of 44
Search research articles
Search
Showing results (171-180 of 432) with videos related to
Sort By:
Page
of 44
Thrombosis Et Diathesis Haemorrhagica
|
December 31, 1974
Fibrinogen Valencia. A new case of congenital dysfibrinogenemia
J Aznar, A Fernandez-Pavón, E Regañón, et al.
The Journal of Antimicrobial Chemotherapy
|
May 1, 1996
Comparative in-vitro activity of sparfloxacin against genital pathogens
E J Perea, J Aznar, M C Garcia-Iglesias, et al.
Thrombosis and Haemostasis
|
August 24, 1999
Intraindividual variability in plasma viscosity in relation to their utility as a cardiovascular risk factor
A Vayá, M Martínez, C Ortuño, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
May 1, 1981
Clinical experience with cefotaxime (HR-756) in surgical patients
J Aznar, E Muñoz, M C García-Iglesias, et al.
Sangre
|
January 1, 1975
[Fibrinolytic activity of human endometrium saline extract (author's transl)]
J J Parrilla, J Aznar, A Estelles, et al.
Thrombosis Research
|
December 15, 1989
Aprotinin (trasylol) is a competitive inhibitor of activated protein C
F España, A Estelles, J H Griffin, et al.
Thrombosis Research
|
November 15, 1989
Incidence of increased plasminogen activator inhibitor in patients with deep venous thrombosis and/or pulmonary embolism
M D Tabernero, A Estellés, V Vicente, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
March 1, 1989
[In situ hybridization with DNA probe for the diagnosis of Neisseria gonorrhoeae infections]
J C Palomares, M C Lozano, J Aznar, et al.
Thrombosis and Haemostasis
|
April 30, 1976
Changes in human amniotic fluid fibrinolytic inhibitor levels during pregnancy
J Aznar, A Hernandez, J J Parrilla, et al.
Atherosclerosis
|
January 1, 1984
Effect of smoking on plasma and platelet fatty acid composition in middle-aged men
M T Santos, J Valles, J Aznar, et al.
Page
of 44